APPLICATION
ANDA090384
TYPE
ANDA
ORIGINAL APPROVAL
2022-05-25
LATEST ACTION
2023-09-25
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
PEMETREXED DISODIUMPrescription
PEMETREXED DISODIUM EQ 750MG BASE/VIAL · POWDER · INTRAVENOUS
PEMETREXED DISODIUMPrescription
PEMETREXED DISODIUM EQ 100MG BASE/VIAL · POWDER · INTRAVENOUS
PEMETREXED DISODIUMPrescription
PEMETREXED DISODIUM EQ 1GM BASE/VIAL · POWDER · INTRAVENOUS
PEMETREXED DISODIUMPrescription
PEMETREXED DISODIUM EQ 500MG BASE/VIAL · POWDER · INTRAVENOUS
Approval history
2023-09-25Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.